Literature DB >> 7917333

DNA-binding domains: targets for viral and cellular regulators.

S Wagner1, M R Green.   

Abstract

Specific DNA binding by eukaryotic transcription factors is conferred by several types of sequence motif. These domains have been extensively studied with regard to their precise interaction with DNA and the basis of sequence specificity. Evidence is accumulating that DNA-binding domains serve functions in addition to binding DNA: they are also targets of viral and cellular regulatory proteins.

Mesh：

Substances：

Year:  1994        PMID： 7917333     DOI： 10.1016/0955-0674(94)90034-5

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN： 0955-0674            Impact factor:   8.382


  6 in total

1.  Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction.

Authors:  S Y Lin; A R Black; D Kostic; S Pajovic; C N Hoover; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Interactions between distinct types of DNA binding proteins enhance binding to ocs element promoter sequences.

Authors:  B Zhang; W Chen; R C Foley; M Büttner; K B Singh
Journal:  Plant Cell       Date:  1995-12       Impact factor: 11.277

3.  c-Maf interacts with c-Myb to regulate transcription of an early myeloid gene during differentiation.

Authors:  S P Hedge; A Kumar; C Kurschner; L H Shapiro
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  Ubiquitination and degradation of ATF2 are dimerization dependent.

Authors:  S Y Fuchs; Z Ronai
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities.

Authors:  W Min; S Ghosh; P Lengyel
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

6.  Characterization of binding between SF-1 and Sp1: predominant interaction of SF-1 with the N-terminal region of Sp1.

Authors:  T Sugawara; E Nomura; A Nakajima; N Sakuragi
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.